Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Staphylococcal protein A - Protalex

Drug Profile

Staphylococcal protein A - Protalex

Alternative Names: PRTX-001; PRTX-100

Latest Information Update: 19 Jul 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Protalex
  • Class Antirheumatics; Bacterial proteins; Immunotherapies
  • Mechanism of Action B cell inhibitors; Immunomodulators; Macrophage inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Idiopathic thrombocytopenic purpura
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Idiopathic thrombocytopenic purpura; Rheumatoid arthritis
  • Preclinical Myasthenia gravis
  • No development reported Autoimmune disorders

Most Recent Events

  • 02 Jul 2019 Protalex terminates a phase I/II trial in Idiopathic thrombocytopenic purpura in USA and United Kingdom as enough data had been collected to allow analysis of safety profile and risk-benefit (IV) (NCT02401061)
  • 24 Jun 2018 Biomarkers information updated
  • 14 Jun 2018 Efficacy and adverse events data in Idiopathic thrombocytopenic pupurea (ITP) presented at 23rd Congress of the European Haematology Association (EHA- 2018)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top